Literature DB >> 2314397

Detection of Borrelia burgdorferi DNA by the polymerase chain reaction.

S L Nielsen1, K K Young, A G Barbour.   

Abstract

DNA amplification by the polymerase chain reaction (PCR) was used to detect DNA of the Lyme disease spirochaete Borrelia burgdorferi. Primers that specify the amplification of a 145 basepair DNA fragment of the OspA gene of B. burgdorferi were used. The amplification product was detected by gel electrophoresis and ethidium bromide staining or by hybridization to a radiolabelled oligonucleotide probe. The hybridization method was found to be more sensitive. As little as 50 fg of purified B. burgdorferi DNA could be detected by PCR. This corresponds to fewer than 50 spirochaetes. The specificity of PCR for B. burgdorferi was tested by using DNA from other organisms as templates for amplification. No cross-reactivity was found. The data shown provide useful information for the development of a PCR-based diagnostic test for Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314397     DOI: 10.1016/0890-8508(90)90041-w

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  16 in total

1.  Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis.

Authors:  R T Marconi; C F Garon
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

3.  Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi.

Authors:  P A Rosa; D Hogan; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

4.  Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases.

Authors:  M E Bayer; L Zhang; M H Bayer
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

5.  Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins.

Authors:  M Jonsson; L Noppa; A G Barbour; S Bergström
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Detection of the Lyme disease bacterium, Borrelia burgdorferi, by using the polymerase chain reaction and a nonradioisotopic gene probe.

Authors:  D J Wise; T L Weaver
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Comparison of polymerase chain reaction and culture for detection of Borrelia burgdorferi in naturally infected Peromyscus leucopus and experimentally infected C.B-17 scid/scid mice.

Authors:  E K Hofmeister; R B Markham; J E Childs; R R Arthur
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

8.  Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis.

Authors:  L A Magnarelli; E Fikrig; R Berland; J F Anderson; R A Flavell
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

9.  Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease.

Authors:  W Melchers; J Meis; P Rosa; E Claas; L Nohlmans; R Koopman; A Horrevorts; J Galama
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

10.  An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types.

Authors:  H Michel; B Wilske; G Hettche; G Göttner; C Heimerl; U Reischl; U Schulte-Spechtel; V Fingerle
Journal:  Med Microbiol Immunol       Date:  2003-09-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.